SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
Spyre Therapeutics, Inc.
@SYRE_InsiderForm 4 Filing: Burrows Scott L Sells $825,521 of $SYRE
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Spyre Therapeutics, Inc.
Ticker: $SYRE
Transaction Value
$825,521
Price/Share: $55.03
transaction date
2026-08-03
Shares: 15,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Burrows Scott L, holds the title of Chief Financial Officer at Spyre Therapeutics, Inc..
On 2026-08-03, the insider transacted 15,000 shares.The shares were transacted at a weighted average price of $55.03 per share, resulting in a total market-relevant value of $825,521.
Executive Summary Summary
Burrows Scott L (Chief Financial Officer) sold $826K of $SYRE
Post-Transaction Position: 100,394 shares
SEC Accession No: 0001636282-26-000100 (CIK: 1853327)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.